SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001013762-23-004246
Filing Date
2023-10-17
Accepted
2023-10-17 08:45:02
Documents
4
Period of Report
2023-10-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea186872-6k_neurosense.htm 6-K 10942
2 PRESS RELEASE, DATED OCTOBER 17, 2023 ea186872ex99-1_neurosense.htm EX-99.1 15602
3 GRAPHIC ex99-1_001.jpg GRAPHIC 11158
4 GRAPHIC ex99-1_002.jpg GRAPHIC 28205
  Complete submission text file 0001013762-23-004246.txt   82067
Mailing Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562
Business Address 11 HAMENOFIM ST. BUILDING B HERZLIYA L3 4672562 972-9-9531142
NeuroSense Therapeutics Ltd. (Filer) CIK: 0001875091 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41084 | Film No.: 231328547
SIC: 2834 Pharmaceutical Preparations